With the Veris Cancer Care Platform, cancer care teams at the New Jersey Cancer Care, PA can now review patients’ physiologic and clinical data in real time and deliver personalized care.
WHY IT MATTERS
Today, NJCC and Veris Health, a subsidiary of New York-based PAVmed Digital Health, announced that the cloud-based clinician portal was successfully integrated into the oncology practice’s information technology systems.
The partners say that patients also began reporting symptoms and general health and quality of life information to their cancer care team through the Veris patient smartphone app. The app also allows caregivers and families to follow the patient’s journey.
“We successfully onboarded our initial group of patients from whom we collected baseline readings prior to sending them home for remote monitoring,” said Denise Johnstone, NJCC’s executive director.
More patients are scheduled for enrollment this week, she said.
With the integration, the NJCC can bill for RPM services on a monthly basis, according to the digital health company.
THE LARGER TREND
Precision medicine approaches to cancer care require the management of high volumes of varied and granular data, but it’s a priority for provider investments.
Chief information officers told Healthcare IT News last year that they believe the future of healthcare – including precision oncology – integrates remote patient monitoring and hospital-at-home technologies to improve both patient care and address the high costs of healthcare.
“Cancer care and chronic disease management are burdensome to patients, communities and health systems. Concentrating resources to prevent these conditions will benefit us all,” said Matt Hocks, chief operating officer at Sioux Falls, South Dakota-based Sanford Health.
“We will be investing in hospital-at-home and remote patient monitoring features in-depth, along with other patient engagement functions, to empower our population and maintain low-touch care to minimize costs,” Mike Mistretta, vice president and CIO at Virginia Hospital Center in Arlington, added.
The government is also investing in precision oncology.
In August, the National Cancer Institute, part of the National Institutes of Health, granted $23 million to develop telehealth oncology technologies that can reduce in-person visits, improve patient experiences and support clinicians in their work.
ON THE RECORD
“New Jersey Cancer Care is thrilled to have officially launched Veris CCP across our practice as it allows us to leverage a groundbreaking RPM tool that will further augment the level of personal care that we demand, and our patients deserve,” Stone said in the announcement.
“Early reports of our platform already having a real impact on clinical care are very gratifying,” added Dr. Lishan Aklog, PAVmed’s chairman and CEO and executive chairman of Veris.
Andrea Fox is senior editor of Healthcare IT News.
Healthcare IT News is a HIMSS Media publication.